Another reason for the low efficiency of cancer treatment is the development of acquired resistance of tumor cells to chemotherapeutic agents, which is frequently caused by the overexpression of specific drug-transporting proteins—ABCB1 (P-glycoprotein), ABCC1 (MRP-1), or ABCG2 (Bcrp) [3]. This evidence concerns the gene ABCG2 and cancer.